Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-21-059245
Filing Date
2021-04-30
Accepted
2021-04-30 17:18:55
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm212442d2_defa14a.htm DEFA14A 18361
2 GRAPHIC tm212442d2_defa14aimg001.jpg GRAPHIC 388549
3 GRAPHIC tm212442d2_defa14aimg002.jpg GRAPHIC 257924
  Complete submission text file 0001104659-21-059245.txt   910115
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36306 | Film No.: 21879819
SIC: 2834 Pharmaceutical Preparations